GSK8573
GSK8573 is an inactive structural analog of the BRD9 inhibitor GSK2801, serving as a negative control compound. It binds to BRD9 with a Kd of 1.04 μM and is used in both in vitro and in vivo studies to validate the on-target effects of bromodomain inhibitors in epigenetics and cancer research.
Product Specifications
CAS Number
1693766-04-9
Product Name Alternative
Control compound, BRD9, biological, BAZ2A, BAZ2B, EpigeneticReaderDomain, Epigenetic Reader Domain, GSK 8573, GSK8573, GSK-8573, Inhibitor, inhibit
Field of Research
Epigenetics & Chromatin
Purity
99.81% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.18 mM) ; DMSO:22 mg/mL (68.03 mM)
Smiles
CCCOc1ccn2c (cc (-c3cccc (OC) c3) c2c1) C (C) =O
Molecular Formula
C20H21NO3
Molecular Weight
323.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7020556-01 0.02 mg
Recombinant Staphylococcus aureus Putative antiporter subunit mnhF2 (mnhF2)
Sign In for Pricing
View Details MBS7020556-02 0.1 mg
Recombinant Staphylococcus aureus Putative antiporter subunit mnhF2 (mnhF2)
Sign In for Pricing
View Details MBS7020556-03 5x 0.1 mg
Recombinant Staphylococcus aureus Putative antiporter subunit mnhF2 (mnhF2)
Sign In for Pricing
View Details 